miRNA-214: expression, therapeutic and diagnostic potential in cancer

Hengpeng He1, Hao Zhang, Zhiguo Li

  • 1Department of Laboratory, The Fourth Affiliated Hospital of China Medical University, Shenyang - China.

Tumori
|June 26, 2015
PubMed

Insights

MicroRNAs (miRNAs) are small molecules that regulate genes and are involved in cancer. This review clarifies the complex roles of miRNA-214, highlighting its potential as a cancer biomarker and therapeutic target.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • MicroRNAs (miRNAs) are small noncoding RNAs regulating gene expression.
  • miRNAs play critical roles in the initiation and progression of human cancers.
  • miRNA-214 exhibits complex roles, acting as both a tumor suppressor and oncogene.

Purpose of the Study:

  • To review and clarify the multifaceted functions of miRNA-214.
  • To emphasize the therapeutic and diagnostic potential of miRNA-214 in cancer.
  • To highlight miRNA-214 as a potential cancer biomarker.

Main Methods:

  • Literature review of studies on miRNA-214.
  • Analysis of miRNA-214's role in differentiation, senescence, angiogenesis, and cell migration.
  • Examination of miRNA-214's dual role as a tumor suppressor and oncogene.

Main Results:

  • miRNA-214 is implicated in various cellular processes, including differentiation, senescence, angiogenesis, and cell migration.
  • miRNA-214 demonstrates context-dependent functions, acting as both a tumor suppressor and an oncogene.
  • Evidence suggests miRNA-214's utility as a biomarker in specific cancer types.

Conclusions:

  • miRNA-214 possesses complex regulatory functions in cancer.
  • miRNA-214 holds significant promise for cancer diagnostics and therapeutics.
  • Further research is warranted to fully elucidate and exploit miRNA-214's potential.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.7K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K